BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 11479482)

  • 1. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H
    Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study.
    Galve E; Rius T; Ballester R; Artaza MA; Arnau JM; García-Dorado D; Soler-Soler J
    J Am Coll Cardiol; 1996 Apr; 27(5):1079-82. PubMed ID: 8609324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium sulfate versus placebo for paroxysmal atrial fibrillation: a randomized clinical trial.
    Chu K; Evans R; Emerson G; Greenslade J; Brown A
    Acad Emerg Med; 2009 Apr; 16(4):295-300. PubMed ID: 19207134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation.
    Davey MJ; Teubner D
    Ann Emerg Med; 2005 Apr; 45(4):347-53. PubMed ID: 15795711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
    Madonia S; De Simone M; Brai G; Gozzo D; Gristina A; Luciano L; Maisano S; Migliore G; Mineo R; Muzzo MP; Nicchi F; Randazzo A; Raspanti G; Rotolo G; Russo A; Sagona F; Schirosa M; Spinello M; Stancampiano R; Geraci E
    Ital Heart J; 2000 Jul; 1(7):475-9. PubMed ID: 10933330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
    Kosior DA; Kochanowski J; Scisło P; Piatkowski R; Postuła M; Rabczenko D; Opolski G
    Cardiol J; 2009; 16(6):521-7. PubMed ID: 19950088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate.
    Hofmann R; Steinwender C; Kammler J; Kypta A; Leisch F
    Int J Cardiol; 2006 Jun; 110(1):27-32. PubMed ID: 16046015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
    Cotter G; Blatt A; Kaluski E; Metzkor-Cotter E; Koren M; Litinski I; Simantov R; Moshkovitz Y; Zaidenstein R; Peleg E; Vered Z; Golik A
    Eur Heart J; 1999 Dec; 20(24):1833-42. PubMed ID: 10581142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical decision analysis modeling: short-term control of ventricular response rate in atrial fibrillation or atrial flutter-digoxin versus diltiazem.
    Gonzalez ER; Ornato JP; Lawson CL
    Pharmacotherapy; 1994; 14(4):446-51. PubMed ID: 7937281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of intravenous amiodarone for the conversion of chronic atrial fibrillation. Amiodarone vs quinidine for conversion of atrial fibrillation.
    Kerin NZ; Faitel K; Naini M
    Arch Intern Med; 1996 Jan; 156(1):49-53. PubMed ID: 8526696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.
    Siu CW; Lau CP; Lee WL; Lam KF; Tse HF
    Crit Care Med; 2009 Jul; 37(7):2174-9; quiz 2180. PubMed ID: 19487941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
    Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
    Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
    Hemels ME; Van Noord T; Crijns HJ; Van Veldhuisen DJ; Veeger NJ; Bosker HA; Wiesfeld AC; Van den Berg MP; Ranchor AV; Van Gelder IC
    J Am Coll Cardiol; 2006 Sep; 48(5):1001-9. PubMed ID: 16949494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of diltiazem for treating rapid atrial fibrillation in the out-of-hospital setting.
    Wang HE; O'connor RE; Megargel RE; Schnyder ME; Morrison DM; Barnes TA; Fitzkee A
    Ann Emerg Med; 2001 Jan; 37(1):38-45. PubMed ID: 11145769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of intravenous amiodarone and procainamide in the treatment of atrial fibrillation of recent onset.
    Xanthos T; Prapa V; Papadimitriou D; Papadimitriou L
    Minerva Cardioangiol; 2007 Aug; 55(4):433-41. PubMed ID: 17653020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 study.
    del Arco C; Martín A; Laguna P; Gargantilla P;
    Ann Emerg Med; 2005 Nov; 46(5):424-30. PubMed ID: 16271674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous and oral administration of amiodarone for the treatment of recent onset atrial fibrillation after digoxin administration.
    Xanthos T; Bassiakou E; Vlachos IS; Bassiakos S; Michalakis K; Moutzouris DA; Papadimitriou L
    Int J Cardiol; 2007 Oct; 121(3):291-5. PubMed ID: 17434635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass surgery.
    Turk T; Ata Y; Vural H; Ozkan H; Yavuz S; Ozyazicioglu A
    Heart Surg Forum; 2007; 10(4):E299-303. PubMed ID: 17599879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation.
    Roy D; Rowe BH; Stiell IG; Coutu B; Ip JH; Phaneuf D; Lee J; Vidaillet H; Dickinson G; Grant S; Ezrin AM; Beatch GN;
    J Am Coll Cardiol; 2004 Dec; 44(12):2355-61. PubMed ID: 15607398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.